Tomas Kiselak
Board Member
Spyre Therapeutics, Inc. (SYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tomas Kiselak
Tomas Kiselak is recorded as Board Member at Spyre Therapeutics, Inc. (SYRE). Spyre Therapeutics, Inc. reported in an 8-K filed June 23, 2023 that Tomas Kiselak was appointed Board, effective June 22, 2023.
“on June 22, 2023, effective immediately after the Effective Time, Peter Harwin, Tomas Kiselak and Michael Henderson were appointed to the Board as directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Spyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cameron Turtle CEO, COO, Board Member
- Cameron Turtle, DPhil CEO, Board Member
- James Kastenmayer CEO
- Jeffrey M. Goldberg CEO
- Scott Burrows CFO, Chief Accounting Officer
- Heidy Abreu King-Jones General Counsel
- Jonathan Alspaugh Chief Accounting Officer
- Steven Weber Chief Accounting Officer
- Jeffrey Albers Board Member
- Laurie Stelzer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.